Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
European Respiratory Journal · 2024-06 · 63 (6) · 2301689
DOI: 10.1183/13993003.01689-2023 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Respiratory Journal, online erschienen am 12.04.2024. Verfasst von Arietta Spinou und 38 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Hauptthemen laut MEDLINE: Bronchiectasis, Registries. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Respiratory Society.
Abstract (Originalsprache)
Background
International guidelines recommend airway clearance management as one of the important pillars of bronchiectasis treatment. However, the extent to which airway clearance is used for people with bronchiectasis in Europe is unclear. The aim of the study was to identify the use of airway clearance management in patients with bronchiectasis across different countries and factors influencing airway clearance use.
Methods
This was a prospective observational study using data from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) Registry between January 2015 and April 2022. Prespecified options for airway clearance management were recorded, including airway clearance techniques, devices and use of mucoactive drugs.
Results
16 723 people with bronchiectasis from 28 countries were included in the study. The mean age was 67 years (interquartile range 57–74 years, range 18–100 years) and 61% were female. 72% of the participants reported daily sputum expectoration and 52% (95% CI 51–53%) of all participants reported using regular airway clearance management. Active cycle of breathing technique was used by 28% of the participants and airway clearance devices by 16% of participants. The frequency of airway clearance management and techniques used varied significantly between different countries. Participants who used airway clearance management had greater disease severity and worse symptoms, including a higher daily sputum volume, compared to those who did not use it regularly. Mucoactive drugs were also more likely to be used in participants with more severe disease. Access to specialist respiratory physiotherapy was low throughout Europe, but particularly low in Eastern Europe.
Conclusions
Only a half of people with bronchiectasis in Europe use airway clearance management. Use of and access to devices, mucoactive drugs and specialist chest physiotherapy appears to be limited in many European countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Population Health Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- King's Centre for Lung Health, King's College London, London, UK.
- A. Spinou and B. Herrero-Cortina contributed equally to this paper.
- Universidad San Jorge, Zaragoza, Spain.
- Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
- Instituto de Investigación Sanitaria (IIS) de Aragón, Zaragoza, Spain.
ORCID-Profile: Arietta Spinou, Stefano Aliberti, Anthony De Soyza, Pierre Regis Burgel, Melissa McDonnell, Apostolos Bossios, Antoni Torres, Natalie Lorent, Tobias Welte, Mateja Jankovic Makek, Michal Shteinberg, Felix C Ringshausen
Förderung
- European Respiratory Society
Zitieren
APA
Spinou, A., Hererro-Cortina, B., Aliberti, S., Goeminne, P. C., Polverino, E., Dimakou, K., Haworth, C. S., Loebinger, M. R., De Soyza, A., Vendrell, M., Burgel, P. R., McDonnell, M., Sutharsan, S., Škrgat, S., Maiz-Carro, L., Sibila, O., Stolz, D., Kauppi, P., Bossios, A., …, & EMBARC Registry Collaborators (2024). Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). European Respiratory Journal, 63(6), 2301689. https://doi.org/10.1183/13993003.01689-2023
Vancouver
Spinou A, Hererro-Cortina B, Aliberti S, Goeminne PC, Polverino E, Dimakou K, et al. Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). European Respiratory Journal. 2024;63(6):2301689. doi:10.1183/13993003.01689-2023
BibTeX
@article{Spinou2024,
author = {Spinou, Arietta and Hererro-Cortina, Beatriz and Aliberti, Stefano and Goeminne, Pieter C and Polverino, Eva and Dimakou, Katerina and Haworth, Charles S and Loebinger, Michael R and De Soyza, Anthony and Vendrell, Montserrat and Burgel, Pierre Regis and McDonnell, Melissa and Sutharsan, Sivagurunathan and Škrgat, Sabina and Maiz-Carro, Luiz and Sibila, Oriol and Stolz, Daiana and Kauppi, Paula and Bossios, Apostolos and Hill, Adam T and Clifton, Ian and Crichton, Megan L and Walker, Paul and Menendez, Rosario and Borekci, Sermin and Obradovic, Dusanka and Nowinski, Adam and Amorim, Adelina and Torres, Antoni and Lorent, Natalie and Welte, Tobias and Blasi, Francesco and Jankovic Makek, Mateja and Shteinberg, Michal and Boersma, Wim and Elborn, J Stuart and Chalmers, James D and Ringshausen, Felix C and EMBARC Registry Collaborators, EMBARC Registry Collaborators},
title = {Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)},
journal = {European Respiratory Journal},
year = {2024},
volume = {63},
number = {6},
pages = {2301689},
doi = {10.1183/13993003.01689-2023}
}
EUVIMED